XDx Launches AlloMap® Molecular Expression Testing in Germany SunHerald.com AlloMap is XDx's easy and convenient, non-invasive blood test that aids physicians in determining a stable heart transplant patient's risk of acute cellular rejection without requiring the use of endomyocardial biopsy. Heart transplant specialists ... |
